Sealants for fetal membrane repair
The present invention provides a method for preventing or repairing damage to a fetal membrane. In one embodiment, the method comprises contacting a fetal membrane with a composition comprising a four-armed catechol-terminated polyethylene glycol (cPEG) and a biocompatible oxidant. In one embodiment, the four-armed cPEG and the biocompatible oxidant are initially contained in separate solutions, and the solutions are mixed to form the composition just prior to or at the same time that the composition contacts the fetal membrane.
1. A method for repairing damage to a fetal membrane comprising contacting a fetal membrane with a composition comprising a four-armed catechol-terminated polyethylene glycol (cPEG) and a biocompatible oxidant.
2. The method of claim 1 , wherein the four-armed cPEG and the biocompatible oxidant are initially contained in separate solutions, and wherein the solutions are mixed to form the composition just prior to or at the same time that the composition contacts the fetal membrane.
3. The method of claim 2 , wherein the step of contacting the fetal membrane with the composition is performed using a double barrel syringe mixer/applicator to mix and direct the composition onto the fetal membrane tissue.
4. The method of claim 3 , wherein before the composition is applied to the fetal membrane tissue, the solution containing the four-armed cPEG is added to one barrel of the syringe mixer/applicator, and the solution containing the oxidant is added to the other barrel of the mixer/applicator.
5. The method of claim 1 , wherein the four-armed cPEG has the structural formula:
6. The method of claim 5 , wherein n is 55.
7. The method of claim 1 , wherein the oxidant is sodium iodate, Iron (III) chloride, a peroxide, oxygen, an inorganic base, an organic base, or an oxidase.
8. The method of claim 1 , wherein the oxidant is a periodate.
9. The method of claim 8 , wherein the periodate is sodium periodate.
10. The method of claim 1 , wherein the composition further comprises an aqueous buffer solution.
11. The method of claim 10 , further comprising the step of dissolving the four-armed cPEG in the aqueous buffer solution before the composition is contacted with the fetal membrane tissue.
12. The method of claim 1 , wherein the method is performed immediately before, during, or immediately after fetal endoscopic surgery.
13. The method of claim 12 , wherein the composition is contacted with the fetal membrane at the endoscopic access site.